A detailed history of Creative Planning transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Creative Planning holds 42,151 shares of IRWD stock, worth $148,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,151
Previous 37,402 12.7%
Holding current value
$148,793
Previous $243,000 28.81%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$3.93 - $7.04 $18,663 - $33,432
4,749 Added 12.7%
42,151 $173,000
Q2 2024

Aug 15, 2024

SELL
$5.58 - $8.61 $68,059 - $105,016
-12,197 Reduced 24.59%
37,402 $243,000
Q1 2024

May 10, 2024

SELL
$8.32 - $15.45 $339,930 - $631,240
-40,857 Reduced 45.17%
49,599 $432,000
Q4 2023

Feb 14, 2024

BUY
$8.79 - $11.51 $196,693 - $257,559
22,377 Added 32.87%
90,456 $1.03 Million
Q3 2023

Nov 16, 2023

SELL
$8.25 - $11.35 $37,743 - $51,926
-4,575 Reduced 6.3%
68,079 $655,000
Q2 2023

Jul 21, 2023

BUY
$10.1 - $11.6 $57,317 - $65,830
5,675 Added 8.47%
72,654 $773,000
Q1 2023

May 15, 2023

BUY
$10.37 - $12.56 $99,883 - $120,977
9,632 Added 16.8%
66,979 $704,000
Q4 2022

Feb 10, 2023

BUY
$9.9 - $12.43 $278,813 - $350,066
28,163 Added 96.5%
57,347 $710,000
Q3 2022

Nov 03, 2022

BUY
$10.14 - $12.38 $27,641 - $33,747
2,726 Added 10.3%
29,184 $302,000
Q3 2021

Nov 10, 2021

SELL
$11.92 - $13.92 $927,912 - $1.08 Million
-77,845 Reduced 74.63%
26,458 $346,000
Q2 2021

Aug 04, 2021

BUY
$10.16 - $13.11 $1.06 Million - $1.37 Million
104,303 New
104,303 $1.34 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.